1. S. I. Gavrilova, Ya. B. Fedorova, I. F. Roshchina, and G. I. Korovaitseva, “Prognosis of mild cognitive deficit syndrome, data from a two-year prospective clinical study,” Nevrol. Psikhiat., 107, No. 1, 4–10 (2007).
2. S. I. Gavrilova, Ya. B. Fedorova, I. V. Kolykhalov, et al., “The therapeutic potential of Cerebrolysin in the preventative treatment of Alzheimer’s disease,” Nevrol. Psikhiat., No. 8, 24–28 (2008).
3. S. I. Gavrilova, I. V. Kolykhalov,Ya. B. Fedorova, et al., “The possibility of preventative treatment of Alzheimer’s disease: results of a 3-year prospective open comparative study of the efficacy and safety of courses of Cerebrolysin and Cavinton in elderly patients with mild cognitive deficit syndrome,” Nevrol. Psikhiat., 110, No. 1, 62–69 (2010).
4. G. I. Korovaitseva, T. V. Shcherbatykh, N. V. Selezneva, et al., “Genetic associations between alleles of the apolipoprotein E (ApoE) gene and different forms of Alzheimer’s disease,” Genetika, 37, No. 4, 529–535 (2001).
5. S. A. Sudakov, Cluster Analysis in Psychiatry and Clinical Psychology [in Russian], A. S. Tiganov (ed.), MIA, Moscow (2010).